Allergic Rhinitis and Rhinoconjunctivitis - Completed
- Stallergenes Greer SL75.14:A Randomized, double-blind, placebo-controlled, multi-center study of the Efficacy and Safety of STG320 sublingual tablet of house dust mite (HDM) allergen extracts in adults and adolescents with HDM-associated allergic rhinitis
- Glenmark GSP 301-305: A Double-Blind, Randomized, Parallel-Group Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Dose Combination GSP 301 Nasal Spray Compared with Placebo Nasal Spray in Pediatric Subjects (aged 6 to under 12 years) With Seasonal Allergic Rhinitis (SAR)
- ALK-Abelló A/S P05607: A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma
- Circassia TH005:A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
- Regeneron R1908-1909-ALG-2102: A Randomized, Double-Blind, Placebo-Controlled Study in Cat-Allergic Patients with Allergic Rhinitis who Live with a Cat to Assess the Efficacy and Safety of Anti-Fel D 1 Antibodies During Natural Cat Exposure in the Home.
